Compound Detail
CHEMBL4879382
Enter ChEMBL ID:
Free Research Context
This compound will appear in recent viewed items on the research home for this browser.
Research home
View demo workspace
Basic Information
| ChEMBL ID | CHEMBL4879382 |
| Phase | Preclinical |
| Structure Type | MOL |
| InChI Key | PCCUELXLCAUZRN-UHFFFAOYSA-N |
7
Targets
7
Activities
1
Assay Types
0
PK Parameters
8
Publications
0
Known Names
Molecular Properties
358.4
MW (Da)
3.46
ALogP
4
HBA
2
HBD
61.8
PSA (Ų)
0.86
QED
0
Ro5 Violations
5
Rot. Bonds
Drug Information
| Molecule Type | Unknown |
| Availability | Unknown |
| Chirality | Unknown |
Activity Summary
IC50 7 meas. best 7.96
Target Activity Profile
| Target | Type | Best pChEMBL | Mean pChEMBL | Best (nM) | # Data |
|---|---|---|---|---|---|
| K562 CHEMBL385 | IC50 | 7.96 | 7.96 | 11.0 | 1 |
| A-431 CHEMBL614069 | IC50 | 7.6 | 7.6 | 25.0 | 1 |
| HepG2 CHEMBL395 | IC50 | 7.58 | 7.58 | 26.0 | 1 |
| HCT-8 CHEMBL613510 | IC50 | 7.54 | 7.54 | 29.0 | 1 |
| H22 CHEMBL614998 | IC50 | 7.5 | 7.5 | 32.0 | 1 |
| MDA-MB-231 CHEMBL400 | IC50 | 7.07 | 7.07 | 86.0 | 1 |
| L02 CHEMBL4296457 | IC50 | 7.06 | 7.06 | 88.0 | 1 |
Activity Data Samples
Top measurements by pChEMBL value
| Target | Type | Rel. | Value | Units | pChEMBL | Assay | PubMed |
|---|---|---|---|---|---|---|---|
| K562 | IC50 | = | 11.0 | nM | 7.96 | Antiproliferative activity against human K562 cells assessed as reduction in cel... | 33676300 |
| A-431 | IC50 | = | 25.0 | nM | 7.6 | Antiproliferative activity against human A-431 cells assessed as reduction in ce... | 33676300 |
| HepG2 | IC50 | = | 26.0 | nM | 7.58 | Antiproliferative activity against human HepG2 cells assessed as reduction in ce... | 33676300 |
| HCT-8 | IC50 | = | 29.0 | nM | 7.54 | Antiproliferative activity against human HCT-8 cells assessed as reduction in ce... | 33676300 |
| H22 | IC50 | = | 32.0 | nM | 7.5 | Antiproliferative activity against mouse H22 cells assessed as reduction in cell... | 33676300 |
| MDA-MB-231 | IC50 | = | 86.0 | nM | 7.07 | Antiproliferative activity against human MDA-MB-231 cells assessed as reduction ... | 33676300 |
| L02 | IC50 | = | 88.0 | nM | 7.06 | Cytotoxicity against human L02 cells assessed as reduction in cell viability inc... | 33676300 |
Literature References
| PubMed | DOI | Target Context | # Activities |
|---|---|---|---|
| 33676300 | 10.1016/j.ejmech.2021.113316 | No relevant target | 3 |
| 33676300 | 10.1016/j.ejmech.2021.113316 | A-431 | 1 |
| 33676300 | 10.1016/j.ejmech.2021.113316 | HepG2 | 1 |
| 33676300 | 10.1016/j.ejmech.2021.113316 | K562 | 1 |
| 33676300 | 10.1016/j.ejmech.2021.113316 | HCT-8 | 1 |
| 33676300 | 10.1016/j.ejmech.2021.113316 | MDA-MB-231 | 1 |
| 33676300 | 10.1016/j.ejmech.2021.113316 | H22 | 1 |
| 33676300 | 10.1016/j.ejmech.2021.113316 | L02 | 1 |
Data from ChEMBL 36 via Core Engine